Single-centre experience of percutaneous left atrial appendage closure using the lifetech lambre device for thromboembolic prevention in patients with atrial fibrillation.

17 March 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Kars Neven

Alfried-Krupp-Hospital Ruttenscheid, Essen (Germany)

10 More presentations in this session

Presentation thumbnail

Perception on anticoagulant treatment and treatment convenience for patients switching from a vitamin K antagonist to dabigatran for stroke prophylaxis in atrial fibrillation (RE-SONANCE study)

Doctor R. Tieleman (Groningen, NL)

Abstract Slides

Presentation thumbnail

Left atrial appendage occlusion using novel lambre, amulet and watchman in atrial fibrillation

Doctor S. Chen (Greifswald, DE)

Presentation thumbnail

Thirty-day clinical outcomes after rhythmology procedures in patients with non-valvular atrial fibrillation on apixaban: Results of the AMPER AF study

Professor J. Mansourati (Brest, FR)

Presentation thumbnail

Thirty-day clinical outcomes after an atrial flutter ablation in patients on dabigatran: the STUDY FLUTTER French prospective study

Miss D. Mlayeh (Aulnay sous Bois, FR)

Presentation thumbnail

Vitamin-K antagonists vs. NOAC for resolution of left atrial appendage thrombus in patients with atrial fibrillation.

Doctor N. Wainstejn (Berlin, DE)

Access the full session

Session thumbnail

Poster session 1 - Atrial Fibrillation - Stroke Prevention

The Event

EHRA 2019

17 March - 19 March 2019

You may be interested in

Congress Presentation

Left atrial appendage closure in atrial fibrillation: gaps in knowledge

Congress Presentation

Pros and cons of endocardial left atrial appendage closure

Congress Session

Stroke prevention in atrial fibrillation: do not forget the left atrial appendage!

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources